DK0814791T3 - Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme - Google Patents

Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme

Info

Publication number
DK0814791T3
DK0814791T3 DK96907446T DK96907446T DK0814791T3 DK 0814791 T3 DK0814791 T3 DK 0814791T3 DK 96907446 T DK96907446 T DK 96907446T DK 96907446 T DK96907446 T DK 96907446T DK 0814791 T3 DK0814791 T3 DK 0814791T3
Authority
DK
Denmark
Prior art keywords
treatment
cardiovascular diseases
aminotetralin derivative
aminotetralin
derivative
Prior art date
Application number
DK96907446T
Other languages
Danish (da)
English (en)
Inventor
Paolo Chiesi
Stefano Bongrani
Roberta Razetti
Maurizio Civelli
Alberto Umile
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK0814791T3 publication Critical patent/DK0814791T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96907446T 1995-03-17 1996-03-13 Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme DK0814791T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (1)

Publication Number Publication Date
DK0814791T3 true DK0814791T3 (da) 2002-10-07

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907446T DK0814791T3 (da) 1995-03-17 1996-03-13 Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme

Country Status (31)

Country Link
US (2) US6013678A (de)
EP (2) EP0814791B1 (de)
JP (1) JPH11502211A (de)
KR (1) KR100391143B1 (de)
CN (1) CN1112920C (de)
AT (1) ATE218856T1 (de)
AU (1) AU702656B2 (de)
BR (1) BR9607996A (de)
CA (1) CA2215671A1 (de)
CZ (1) CZ288488B6 (de)
DE (1) DE69621786T2 (de)
DK (1) DK0814791T3 (de)
EA (1) EA000937B1 (de)
EE (1) EE04040B1 (de)
ES (1) ES2177769T3 (de)
HK (1) HK1048060A1 (de)
HU (1) HUP9801686A3 (de)
IL (1) IL117518A (de)
IT (1) IT1275935B1 (de)
LT (1) LT4355B (de)
LV (1) LV11882B (de)
MX (1) MX9706971A (de)
NO (1) NO317402B1 (de)
NZ (1) NZ303993A (de)
PL (1) PL183347B1 (de)
PT (1) PT814791E (de)
SI (1) SI9620036B (de)
SK (1) SK282952B6 (de)
TR (1) TR199700963T1 (de)
WO (1) WO1996029065A2 (de)
ZA (1) ZA962073B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
EP1331004A3 (de) * 1999-06-09 2003-08-06 CHIESI FARMACEUTICI S.p.A. Aminotetralin Derivat zur Behandlung von kardiovaskulären Erkrankungen
EA003830B1 (ru) * 1999-06-09 2003-10-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производное аминотетралина для терапии сердечно-сосудистых заболеваний
IT1313583B1 (it) 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (de) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung der Form I von Nolomirol Hydrochlorid
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
SK125497A3 (en) 1998-02-04
LT97147A (en) 1998-02-25
CN1181699A (zh) 1998-05-13
EA000937B1 (ru) 2000-06-26
LV11882A (lv) 1997-12-20
KR19980703030A (ko) 1998-09-05
MX9706971A (es) 1997-11-29
IL117518A (en) 2001-05-20
IT1275935B1 (it) 1997-10-24
US6103760A (en) 2000-08-15
DE69621786D1 (de) 2002-07-18
SI9620036A (sl) 1998-02-28
AU5107296A (en) 1996-10-08
ZA962073B (en) 1996-11-27
SK282952B6 (sk) 2003-01-09
HK1004802A1 (en) 1998-12-11
ATE218856T1 (de) 2002-06-15
NO317402B1 (no) 2004-10-25
WO1996029065A2 (en) 1996-09-26
EA199700243A1 (ru) 1998-02-26
IL117518A0 (en) 1996-07-23
PT814791E (pt) 2002-10-31
PL322284A1 (en) 1998-01-19
HK1048060A1 (en) 2003-03-21
ITMI950532A1 (it) 1996-09-17
SI9620036B (sl) 2002-10-31
NZ303993A (en) 2000-12-22
CN1112920C (zh) 2003-07-02
NO974267D0 (no) 1997-09-16
EP0814791A1 (de) 1998-01-07
ITMI950532A0 (it) 1995-03-17
JPH11502211A (ja) 1999-02-23
EP1216702A3 (de) 2002-09-04
CZ288488B6 (en) 2001-06-13
LV11882B (en) 1998-03-20
HUP9801686A2 (hu) 1999-06-28
CA2215671A1 (en) 1996-09-26
EP0814791B1 (de) 2002-06-12
PL183347B1 (pl) 2002-06-28
BR9607996A (pt) 1998-06-23
KR100391143B1 (ko) 2003-11-28
EP1216702A2 (de) 2002-06-26
US6013678A (en) 2000-01-11
TR199700963T1 (xx) 1998-02-21
NO974267L (no) 1997-11-07
CZ286697A3 (cs) 1998-03-18
EE9700231A (et) 1998-04-15
EE04040B1 (et) 2003-06-16
ES2177769T3 (es) 2002-12-16
WO1996029065A3 (en) 1996-11-28
DE69621786T2 (de) 2003-01-02
HUP9801686A3 (en) 1999-10-28
LT4355B (lt) 1998-06-25
AU702656B2 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
NO951761D0 (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
ATE239474T1 (de) Verwendung von levobupivacain
IE791235L (en) Acyl-derivatives of carnitine.
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
EE9700231A (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
GR3024707T3 (en) Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
ATE236159T1 (de) Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen
DK0710646T3 (da) 1,5-Disubstituerede 7a-methylperhydroinden-3a-olderivater, der er aktive på det cardiovaskulære system, fremgangsmåder til
DK0385422T3 (da) 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carboxylsyre-(-(N-methyl-N-phenylmethylamino)ethyl)ester-fumarat
IT9048106A0 (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
ITMI950956A0 (it) Uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca